A detailed history of Asset Management One Co., Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 235,474 shares of DXCM stock, worth $18.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
235,474
Previous 213,206 10.44%
Holding current value
$18.9 Million
Previous $24.2 Million 34.72%
% of portfolio
0.06%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$64.0 - $116.06 $1.43 Million - $2.58 Million
22,268 Added 10.44%
235,474 $15.8 Million
Q2 2024

Jul 18, 2024

BUY
$110.31 - $140.45 $156,750 - $199,579
1,421 Added 0.67%
213,206 $24.2 Million
Q1 2024

May 02, 2024

SELL
$114.22 - $140.1 $900,967 - $1.11 Million
-7,888 Reduced 3.59%
211,785 $29.4 Million
Q4 2023

Jan 24, 2024

SELL
$75.49 - $124.16 $327,777 - $539,102
-4,342 Reduced 1.94%
219,673 $27.3 Million
Q3 2023

Oct 19, 2023

BUY
$86.06 - $137.93 $358,870 - $575,168
4,170 Added 1.9%
224,015 $20.9 Million
Q2 2023

Jul 31, 2023

SELL
$112.47 - $130.98 $900,097 - $1.05 Million
-8,003 Reduced 3.51%
219,845 $28.3 Million
Q1 2023

Apr 25, 2023

SELL
$104.0 - $122.92 $340,080 - $401,948
-3,270 Reduced 1.41%
227,848 $26.5 Million
Q4 2022

Feb 06, 2023

SELL
$84.98 - $122.67 $598,004 - $863,228
-7,037 Reduced 2.95%
231,118 $26.2 Million
Q3 2022

Nov 04, 2022

SELL
$76.35 - $94.18 $501,543 - $618,668
-6,569 Reduced 2.68%
238,155 $19.2 Million
Q2 2022

Jul 29, 2022

BUY
$67.99 - $132.89 $12.9 Million - $25.3 Million
190,184 Added 348.71%
244,724 $18.2 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $146,952 - $203,372
-1,562 Reduced 2.78%
54,540 $27.9 Million
Q4 2021

Feb 09, 2022

BUY
$129.87 - $162.82 $191,168 - $239,671
1,472 Added 2.69%
56,102 $30 Million
Q3 2021

Nov 02, 2021

SELL
$106.71 - $143.18 $119,835 - $160,791
-1,123 Reduced 2.01%
54,630 $29.9 Million
Q2 2021

Aug 03, 2021

BUY
$80.99 - $107.93 $2,591 - $3,453
32 Added 0.06%
55,753 $23.8 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $26,793 - $33,097
-316 Reduced 0.56%
55,721 $20 Million
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $153,816 - $206,074
1,972 Added 3.65%
56,037 $20 Million
Q3 2020

Nov 13, 2020

BUY
$95.51 - $112.95 $167,238 - $197,775
1,751 Added 3.35%
54,065 $22.3 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $362,666 - $609,497
-5,786 Reduced 9.96%
52,314 $21.2 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $108,817 - $172,209
2,277 Added 4.08%
58,100 $15.6 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $135,713 - $212,316
-3,706 Reduced 6.23%
55,823 $12.2 Million
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $2,842 - $3,504
80 Added 0.13%
59,529 $8.88 Million
Q2 2019

Aug 14, 2019

BUY
$27.84 - $38.92 $157,407 - $220,053
5,654 Added 10.51%
59,449 $8.91 Million
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $2.89 Million - $3.93 Million
-102,918 Reduced 65.67%
53,795 $6.41 Million
Q4 2018

Feb 13, 2019

BUY
$26.99 - $37.37 $4.03 Million - $5.57 Million
149,153 Added 1972.92%
156,713 $18.8 Million
Q3 2018

Nov 14, 2018

SELL
$23.35 - $36.72 $15,177 - $23,868
-650 Reduced 7.92%
7,560 $1.08 Million
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $76,825 - $110,463
4,380 Added 114.36%
8,210 $777,000
Q1 2018

May 14, 2018

BUY
$13.06 - $18.54 $10,983 - $15,592
841 Added 28.14%
3,830 $284,000
Q4 2017

Feb 14, 2018

SELL
$11.12 - $15.38 $1.44 Million - $1.99 Million
-129,274 Reduced 97.74%
2,989 $172,000
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $29,751 - $49,708
2,619 Added 2.02%
132,263 $6.45 Million
Q2 2017

Aug 14, 2017

BUY
N/A
129,644
129,644 $9.48 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.